Integration of molecular testing for the personalized management of patients with diffuse large B-cell lymphoma and follicular lymphoma

doi:10.5306/wjco.v14.i4.160

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3420)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-1) series.

Item

Count

PDF

186

WORD

HTML

1861

Tables (1-1)

232

Sum=2301

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

158

Download

449

Sum=607

Publishing Process of This Article

Item

Count

Browse

165

Download

347

Sum=512

Apr 24, 2023 (publication date) through Nov 5, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Oncol. Apr 24, 2023; 14(4): 160-170
Published online Apr 24, 2023. doi: 10.5306/wjco.v14.i4.160

Table 1 Frequent mutations detected in follicular lymphoma. Adapted from[32,37]

Gene	Frequency in FL, %
KMT2D	82
CREBBP	65-70
HIST1H1C and/or HIST1H1E	28
EZH2	20-25
EP300	14
STAT6	12
CARD11	11
TNFAIP3	11
SOCS1	8
TP53	6

FL: Follicular lymphoma.

Citation: Stuckey R, Luzardo Henríquez H, de la Nuez Melian H, Rivero Vera JC, Bilbao-Sieyro C, Gómez-Casares MT. Integration of molecular testing for the personalized management of patients with diffuse large B-cell lymphoma and follicular lymphoma. World J Clin Oncol 2023; 14(4): 160-170
URL: https://www.wjgnet.com/2218-4333/full/v14/i4/160.htm
DOI: https://dx.doi.org/10.5306/wjco.v14.i4.160